Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Friday, November 6, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Healthcare
Healthcare
Healthcare
More Than 4,000 Brigham and Women’s Hospital Nurses Plan Open-Ended Strike Beginning November 12
Life Sciences Times
-
November 2, 2026
Healthcare
Baystate Health Integrates Mercy Hospital and 45 Medical Practices, Launches New Electronic Health Record System
Life Sciences Times
-
November 2, 2026
Healthcare
NeoGenomics Reports 11% Revenue Growth to $209 Million, Narrows Third-Quarter Loss
Life Sciences Times
-
October 29, 2026
Healthcare
Cambridge-Based Bild Health Launches App to Help GLP-1 Users Preserve Muscle During Weight Loss
Life Sciences Times
-
October 27, 2026
Healthcare
Daily Peanut Consumption May Improve Brain Insulin Response in Older Adults, Study Finds
Life Sciences Times
-
October 27, 2026
Healthcare
Medically Home Group and Siemens Healthineers Collaborate to Enhance Capabilities for Providing Advanced Patient Care at Home
Life Sciences Times
-
May 14, 2024
0
Healthcare
Steward Health Care Finalizing Financing Deal With Medical Properties Trust to Support Its Restructuring
Life Sciences Times
-
May 6, 2024
0
Healthcare
Ora and Singapore Eye Research Institute Unveil Groundbreaking Partnership to Propel Ophthalmology Innovation Globally
Life Sciences Times
-
May 2, 2024
0
1
...
17
18
19
Page 19 of 19
- Advertisment -
Most Read
Agenus Reports 51% of Colorectal Cancer Patients Survived at Least 18 Months Following Experimental Immunotherapy
November 6, 2026
Verastem Oncology Narrows Third-Quarter Loss to $74.7 Million, Advances KRAS-Targeted Cancer Drug Toward Phase 3 Trials
November 6, 2026
Tandem Diabetes Care Appoints Jeannette Bankes as CEO, Succeeding John Sheridan
November 6, 2026
Sarepta Therapeutics Narrows Third-Quarter Loss to $28.5 Million, Advances Rare Disease Drug Programs
November 6, 2026